US Patent Issued to Compass Therapeutics on Dec. 23 for "Multispecific binding constructs against checkpoint molecules and uses thereof" (Massachusetts, Washington, New Hampshire Inventors)

ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,503,511, issued on Dec. 23, was assigned to Compass Therapeutics LLC (Brighton, Mass.).

"Multispecific binding constructs against checkpoint molecules and uses thereof" was invented by Bing Gong (Brighton, Mass.), Rachel Rennard (Stoneham, Mass.), Amanda Frank Oliphant (Boston), Cheuk Lun Leung (Quincy, Mass.), Benjamin Jacob Wolf (Seattle), Ugur Eskiocak (Somerville, Mass.), Pearl Bakhru (Ashland, Mass.) and Diana I. Albu (Windham, N.H.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to compositions and methods for inhibiting tumor evasion by reducing immune checkpoint suppression. In some embodiments, provided herein are ...